Forecast: Cardiovascular System Medicine Sales in Germany

Year-on-Year Variations (%): The variations for the forecasted years from 2024 to 2028 show a very gradual increase in sales value. From 2024 to 2025, the increase is approximately 0.30%; from 2025 to 2026, around 0.15%; from 2026 to 2027, about 0.15%; and from 2027 to 2028, around 0.15%.

Compound Annual Growth Rate (CAGR): The average annual growth rate over the next 5 years is approximately 0.15%.

Future trends indicate that while the growth in sales value is slow, it remains steady, reflecting a mature market with potential impacts from advances in medical technology, policy changes, and demographic shifts affecting healthcare needs in Germany.

Top Countries about Heart Drug